News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
617,187 Results
Type
Article (44499)
Company Profile (146)
Press Release (572542)
Section
Business (171435)
Career Advice (1684)
Deals (31763)
Drug Delivery (103)
Drug Development (79042)
Employer Resources (95)
FDA (16630)
Job Trends (13621)
News (307570)
Policy (33759)
Tag
Academia (2554)
Alliances (44280)
Alzheimer's disease (1313)
Antibody-drug conjugate (ADC) (94)
Approvals (16540)
Artificial intelligence (150)
Bankruptcy (290)
Best Places to Work (11129)
Biotechnology (107)
Breast cancer (175)
Cancer (1293)
Cardiovascular disease (109)
Career advice (1377)
Cell therapy (258)
Clinical research (63119)
Collaboration (439)
Compensation (221)
COVID-19 (2415)
C-suite (106)
Data (1337)
Diabetes (169)
Diagnostics (5946)
Drug pricing (103)
Earnings (66298)
Events (96795)
Executive appointments (339)
FDA (17266)
Funding (387)
Gene therapy (182)
GLP-1 (665)
Government (4501)
Healthcare (18446)
Infectious disease (2495)
Inflammatory bowel disease (113)
Interviews (302)
IPO (15059)
Job creations (2872)
Job search strategy (1175)
Layoffs (386)
Legal (7318)
Lung cancer (183)
Manufacturing (191)
Medical device (12541)
Medtech (12546)
Mergers & acquisitions (16862)
Metabolic disorders (472)
Neuroscience (1639)
NextGen Class of 2024 (6246)
Non-profit (4342)
Northern California (1595)
Obesity (273)
Opinion (220)
Patents (110)
People (49232)
Phase I (19287)
Phase II (27581)
Phase III (21091)
Pipeline (494)
Postmarket research (2867)
Preclinical (8201)
Radiopharmaceuticals (235)
Rare diseases (256)
Real estate (4647)
Regulatory (23390)
Research institute (2305)
Resumes & cover letters (296)
Southern California (1372)
Startups (3090)
United States (14037)
Vaccines (495)
Weight loss (214)
Date
Today (148)
Last 7 days (639)
Last 30 days (2896)
Last 365 days (34995)
2024 (33827)
2023 (39702)
2022 (49946)
2021 (54075)
2020 (52691)
2019 (45677)
2018 (34618)
2017 (31644)
2016 (29849)
2015 (34515)
2014 (25624)
2013 (21107)
2012 (22664)
2011 (23967)
2010 (21620)
Location
Africa (713)
Arizona (111)
Asia (37026)
Australia (6134)
California (3501)
Canada (1351)
China (286)
Colorado (167)
Connecticut (166)
Europe (84100)
Florida (498)
Georgia (127)
Illinois (354)
Indiana (205)
Maryland (606)
Massachusetts (2726)
Michigan (162)
Minnesota (258)
New Jersey (1026)
New York (1016)
North Carolina (739)
Northern California (1595)
Ohio (140)
Pennsylvania (850)
South America (988)
Southern California (1372)
Texas (487)
Utah (102)
Washington State (351)
617,187 Results for "drug information association".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rallybio Announces Publication of Target-Mediated Drug Disposition Modeling and Simulations Informing the RLYB212 Dosing Regimen in Pregnant Women
November 27, 2024
·
7 min read
Lone Star Bio
The Foundation for Angelman Syndrome Therapeutics (FAST) announces the establishment of an associated drug development accelerator
The Foundation for Angelman Syndrome Therapeutics (FAST) announced the establishment of an associated drug development accelerator called AS2Bio Inc.
June 4, 2024
·
3 min read
BioMidwest
Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting Panel
Telomir Pharmaceuticals, Inc. announced that its scientific advisor, Adam Kaplin, M.D., Ph.D., was invited by InSilicoTrials to speak on its panel discussion on June 17, 2024, at the DIA Global Annual Meeting.
June 17, 2024
·
4 min read
Policy
Association for Diagnostics & Laboratory Medicine (formerly AACC) survey finds that FDA’s final laboratory developed tests rule will impede the fight against the U.S.'s drug epidemic
The Association for Diagnostics & Laboratory Medicine released the results of a survey that ADLM conducted to determine how the Food and Drug Administration’s final laboratory developed tests rule will impact patient access to essential tests.
June 25, 2024
·
4 min read
Deals
Sarepta Aims Up to $10B at Arrowhead to Diversify Pipeline With RNA Drugs
With Elevidys expansion in hand, Sarepta commits up to $10 billion to develop short interfering RNA–based drugs to build out its pipeline.
November 26, 2024
·
2 min read
·
Kate Goodwin
BioMidwest
NeuroTherapia Receives Grant from Alzheimer’s Association for Development of First-in-Class Drug for Alzheimer’s Disease
NeuroTherapia, an early-stage clinical pharmaceutical company, announced that it has received a grant from the Alzheimer’s Association Part the Cloud program for the development of its first-in-class drug, NTRX-07, for the treatment of Alzheimer’s disease.
May 8, 2024
·
2 min read
Opinion
Don’t Import Bad Policy Ideas on Drug Pricing
Suggestions that the U.S. should emulate other countries on drug price controls or patents obscure how our present policies have allowed drug development to flourish.
November 13, 2024
·
4 min read
·
Kirsten Axelsen
Opinion
Drugs Are Becoming ‘Smarter.’ Here’s How
Digitization enables each drug to have a software-enhanced version optimized for individual patients.
November 11, 2024
·
6 min read
·
David Benshoof Klein
BioMidwest
The American Diabetes Association Highlights Innovations in New Drug Therapies for Patients with Obesity
Findings from three studies showcase new data on the latest developments in drug therapy innovations to treat obesity including new insights on GLP-1 receptor agonists.
June 23, 2024
·
9 min read
Drug Development
BridgeBio Wins FDA Approval for ATTR-CM Drug, Launching Competition With Pfizer
BridgeBio secured approval for Attruby Friday, along with the all-important mortality benefit that could give the drug a significant boost in the market against Pfizer’s tafamidis and potentially Alnylam’s Amvuttra.
November 23, 2024
·
8 min read
·
Heather McKenzie
1 of 61,719
Next
